PPH

VanEck Vectors Pharmaceutical ETF
A

55
*Unless otherwise stated, data provided by FactSet.

PPH Fund Description

PPH tracks a market-cap-weighted index of 25 of the largest global pharmaceutical firms.

PPH Factset Analytics Insight

PPH provides exposure to the largest, multinational pharmaceutical giants in the world. The fund holds just 25 securities, including big weights in household names like Johnson & Johnson, Pfizer, and Novartis. Like the underlying pharmaceutical market, PPH is top heavy and has to reweight its big holdings to accommodate RIC diversification requirements, and it excludes Asia entirely. Still, it captures the space well. PPH is cheap to trade and reasonably liquid, with decent daily volume and small spreads. It can be traded cheaply and easily by institutions at the block level, as its portfolio is highly liquid and market makers are extremely active. It's also a fairly efficient, cheaply-held fund, with a low expense ratio and strong tracking. Overall, PPH is a great option for investors seeking exposure to big, multinational pharma companies.

PPH MSCI ESG Analytics Insight

VanEck Vectors Pharmaceutical ETF has an MSCI ESG Fund Rating of BB based on a score of 4.22 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. VanEck Vectors Pharmaceutical ETF ranks in the 23th percentile within its peer group and in the 35th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

PPH CHARTS AND PERFORMANCE

Price Chart ($)
Total Return Chart (%)
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:
PERFORMANCE [as of 07/19/19] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
PPH -1.11% 1.33% 5.41% -4.36% -0.10% 0.31% --
PPH (NAV) -2.70% 0.59% 4.28% -4.30% -0.18% 0.17% --
Thomson Reuters Global Pharmaceuticals -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

PPH Top 10 Countries

PPH Top 10 Sectors

PPH Top 10 Holdings [View All]

PPH Summary Data

VanEck
02/01/00
Open-Ended Fund
0.36%
$159.12M
$2.96M
0.05%

PPH Portfolio Data

$96.29B
-210.33
3.11
1.94%
10/01/19
26

PPH Index Data

MVIS U.S. Listed Pharmaceutical 25 Index
Market Cap
Market Cap
Thomson Reuters Global Pharmaceuticals

PPH Portfolio Management

0.36%
0.02%
0.17%
-0.04%

PPH Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

PPH Fund Structure

Open-Ended Fund
No
Yes
100% / 0%
N/A
N/A
Low
Daily
Cboe Book Viewer
TOP OF BOOK
LAST 10 TRADES
Bats BZX Real-time Quote -
Daily Spread
Premium/Discount
Volume

PPH Factset Analytics Block Liquidity

As of 07/22/19
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of PPH. PPH is rated a 5 out of 5.

PPH Tradability

51,058
$2.96M
26,006
$1.49M
0.05%
$0.03
-0.01%
0.26% / -0.41%
None
100.00%
50,000
0.52
0.02%
0.13%
3,574
$56.73
5

PPH Sector/Industry Breakdown


PPH
Segment Benchmark
85.61%
100.00%
10.42%
--
3.05%
--
0.92%
--

PPH TOP 10 HOLDINGS[View All]

4.90%
Mylan N.V. 4.82%
49.67%

PPH Countries


PPH
Segment Benchmark
64.50%
51.96%
13.16%
6.79%
5.33%
1.77%
5.27%
15.51%
5.12%
3.43%
3.93%
8.44%
2.71%
0.35%
--
2.42%
--
2.38%
--
0.00%

PPH Regions


PPH
Segment Benchmark
64.50%
52.77%
28.87%
31.34%
3.93%
15.30%
2.71%
0.47%
--
0.12%

PPH Economic Development


PPH
Segment Benchmark
100.00%
98.02%
--
1.98%

PPH Performance Statistics

0.72
1.14
1.29
1.20
0.59%
Thomson Reuters Global Pharmaceuticals

PPH MSCI ESG Ratings

BB
4.22 / 10
34.74
22.67
--
13.37%
30.71

PPH BENCHMARK COMPARISON HOLDINGS

26
324
20
47.53%

PPH BENCHMARK COMPARISON SUMMARY


PPH
Segment Benchmark
26
324
$96.29B
$146.85B
-210.33
27.20
3.11
3.74
2.44%
2.73%
High
High

PPH BENCHMARK COMPARISON MARKET CAP SIZE


PPH
Segment Benchmark
75.83%
88.06%
22.37%
8.06%
1.80%
2.95%
0.00%
0.93%